News

Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health
Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...
Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge
Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...
Why Eli Lilly (LLY) Stock Is Nosediving
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 11% in the afternoon session after the company reported ...
Investor's Business Daily on MSN2h
Eli Lilly Bounces Back. Zepbound Taking A Back Seat To Novo Nordisk's Wegovy At CVS.
Eli Lilly rose Friday after topping Wall Street's first-quarter expectations. Eli Lilly stock bounced back after tumbling Thursday after CVS' Caremark selected Novo Nordisk's Wegovy as its preferred ...
Stock market today: Nasdaq surges as AI trade reignites amid Big Tech earnings, Dow, S&P 500 rise for 8th day
Microsoft and Meta's strong earnings reports eased investor fears of an economic slowdown amid President Trump's tariffs.